«

»

Eli Lilly Covid-19 Antibody Treatment Granted Emergency FDA Authorization

“This emergency authorization allows us to make bamlanivimab available as a COVID-19 treatment for recently diagnosed, high-risk patients—adding a valuable tool for doctors fighting the now-increasing burden of this global pandemic,” Eli Lilly CEO David Ricks said.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive